Arix Bioscience plc is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting edge advances in life sciences. We collaborate with exceptional entrepreneurs and provide the capital, expertise and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors.
Location: United Kingdom, England, London
Employees: 11-50
Founded date: 2016
Investment Type: Venture Capital
Investment Stage: Series A; Series B; Series C
Portfolio 16
| Date | Name | Website | Total Raised | Location |
| 26.04.2023 | Evommune | evommune.c... | $140.5M | United Sta... |
| 18.03.2019 | Imara | imaratx.co... | $63M | United Sta... |
| 21.12.2017 | Aura Biosc... | aurabiosci... | $183M | United Sta... |
| 04.12.2017 | Atox Bio | atoxbio.co... | $56.25M | United Sta... |
| 27.07.2017 | PRECITHERA... | precithera... | $29M | - |
| 28.06.2017 | LogicBio T... | logicbio.c... | $49M | United Sta... |
| 25.05.2017 | Harpoon Th... | harpoontx.... | $201.25M | United Sta... |
| 19.05.2017 | Iterum The... | iterumtx.c... | $157M | - |
| - | VelosBio | velosbio.c... | $195M | United Sta... |
| - | Depixus | depixus.co... | $35.4M | France, Il... |
Show more
Persons 3
| Date | First Name | Last Name | Title | Location | |||
| - | Debra | Barker | Senior Ind... | - | - | - | |
| - | Debra | Barker | Senior Ind... | - | - | - | |
| - | Tassos | Konstantin... | Managing D... | linkedin.c... | - | - | - |
News 337
Show more
Mentions in press and media 28
| Date | Title | Description | Source |
| 22.12.2021 | Sorriso Pharmaceuticals Launches with $31 Million to Develop... | SALT LAKE CITY, Dec. 22, 2021 /PRNewswire/ -- Sorriso Pharmaceuticals, a company focused on transfor... | marketscre... |
| 02.09.2021 | Arix Bioscience participates in USD90 million Series B finan... | Arix Bioscience PLC (ARIX) Arix Bioscience participates in USD90 million Series B financing for Disc... | marketscre... |
| 14.06.2021 | ARIX BIOSCIENCE PLC Results of Annual General Meeting | Arix Bioscience PLC (ARIX) Results of Annual General Meeting 14-Jun-2021 / 14:55 GMT/BST Disseminati... | marketscre... |
| 18.05.2021 | ARIX BIOSCIENCE PLC Notice of 2021 Annual General Meeting | Arix Bioscience PLC (ARIX) Notice of 2021 Annual General Meeting 18-May-2021 / 07:00 GMT/BST Dissemi... | marketscre... |
| 08.04.2021 | ARIX BIOSCIENCE PLC Arix to Present at the Proactive One2On... | Arix Bioscience PLC Arix to Present at the Proactive One2One Virtual Investor Forum 08-Apr-2021 / 07... | marketscre... |
| 09.03.2021 | ARIX BIOSCIENCE PLC Annual Results for the Twelve Months en... | Arix Bioscience PLC (ARIX) Annual Results for the Twelve Months ended 31 December 2020 09-March-2021... | marketscre... |
| 08.07.2020 | ARIX BIOSCIENCE PLC Arix Bioscience Plc : - VelosBio comple... | Arix Bioscience plc VelosBio completes $137 million Series B financing LONDON, 8 July 2020: Arix B... | marketscre... |
| 09.04.2020 | Frederic Pla enlisted as COO at the Parker Institute;... | Frederic Pla Parker Institute → The Parker Institute for Cancer Immunotherapy has welc... | endpts.com... |
| 13.03.2020 | CureVac’s Ingmar Hoerr tells us why he returned to take... | Ingmar Hoerr On Tuesday, Ingmar Hoerr stood up from his seat at the head of CureVac’s board... | endpts.com... |
| 10.03.2020 | Versant woos MorphoSys' ex-CSO to its booming discovery... | As MorphoSys celebrated the FDA’s acceptance of its first-ever BLA — complete with a priori... | endpts.com... |
Show more